Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
APLLTD Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Analysts have been raising forward EPS estimates
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Negative
Low EPS growth and in line with median growth of industry
Neutral
Moderate and stable ROE
Moderate and stable operating margin
Company's earnings are of moderate quality
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
APLLTD Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
APLLTD Bulk, Block & Insider Trades
APLLTD Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chr... Read More
Key personnel
Mr. Chirayu R. AminD
Executive Chairman of the Board, Chief Executive Officer
G. Krishnan
Chief Financial Officer
Ms. Manisha Saraf
Compliance Officer, Company Secretary
Shri. Pranav C. AminD
Managing Director, Executive Director
Mr. Shaunak AminD
Managing Director, Executive Director
Mr. Raj Kumar BahetiD
Executive Director
Mr. Ashok Kumar Barat, CPAD
Non-Executive Independent Director
Mr. Jai DiwanjiD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Alembic Pharmaceuticals Ltd.?
The current share price of Alembic Pharmaceuticals Ltd. is ₹ 799.92 as of 09 Jan 2026.
What is the PE ratio of Alembic Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Alembic Pharmaceuticals Ltd. is 24.79 as of the latest financial data.
What is the ROE and ROCE of Alembic Pharmaceuticals Ltd.?
Alembic Pharmaceuticals Ltd. has a Return on Equity (ROE) of 12.43% and a Return on Capital Employed (ROCE) of 13.17% as per the latest financial reports.
What is the market cap of Alembic Pharmaceuticals Ltd.?
The market capitalization of Alembic Pharmaceuticals Ltd. stands at ₹ 15,723.50 Cr.
What is the dividend yield of Alembic Pharmaceuticals Ltd.?
The dividend yield of Alembic Pharmaceuticals Ltd. is 1.38% based on the current market price.
What is the RSI of Alembic Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Alembic Pharmaceuticals Ltd. is 23.53.
What is the FII and DII holding in Alembic Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 4.05% and Domestic Institutional Investors (DII) hold 15.98% of Alembic Pharmaceuticals Ltd. shares.
What sector does Alembic Pharmaceuticals Ltd. belong to?
Alembic Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Alembic Pharmaceuticals Ltd. stock?
The beta of Alembic Pharmaceuticals Ltd. stock is 0.67, indicating its volatility relative to the broader market.
